Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-10-2023 | Sunitinib | Case report

Sunitinib

Thrombotic microangiopathy, cerebral infarction and hypertension: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Sasaki K, et al. Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens. Japanese Journal of Clinical Oncology 53: 297-303, No. 4, Jan 2023. Available from: URL: http://doi.org/10.1093/jjco/hyac202 Sasaki K, et al. Sunitinib therapy for imatinib-resistant and/or intolerant gastrointestinal stromal tumors: comparison of safety and efficacy between standard and reduced dosage regimens. Japanese Journal of Clinical Oncology 53: 297-303, No. 4, Jan 2023. Available from: URL: http://​doi.​org/​10.​1093/​jjco/​hyac202
Metadata
Title
Sunitinib
Thrombotic microangiopathy, cerebral infarction and hypertension: 2 case reports
Publication date
01-10-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-48165-3

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue